InvestorsHub Logo
Followers 165
Posts 19872
Boards Moderated 2
Alias Born 12/09/2004

Re: nidan7500 post# 402431

Thursday, 02/09/2023 3:35:35 PM

Thursday, February 09, 2023 3:35:35 PM

Post# of 463672
The answer to this is very simple. Have a company present a drug or treatment that slows the decline or improves the functioning of AD patients that does not attack AD via amyloid.
So far the FDA hasn't seen such a drug or treatment.
I wonder what company will be the first to do that?

B. How does FDA unscrew itself from Amyloid thesis CNS disease past w/a straight face and move on?


If investing was easy, everyone would be rich by now.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News